UTC Therapeutics Inc.
UTC Therapeutics Inc.
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, biliary tract cancer, biliary tract disorder, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, gastric neoplasm, intestinal disorder, neoplasm, rectal disorder, stomach disorder | Recruiting | Early phase 1 | 2026-05-26 | NCT06937567 | |
| UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Not yet recruiting | Phase 1 | 2026-03-30 | NCT07500805 | |
| Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors | HER2-positive Advanced Malignant Solid Tumors | Recruiting | Not applicable | 2026-03-19 | NCT06658951 | |
| Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors | Mesothelin-positive Advanced Malignant Solid Tumors | Recruiting | Not applicable | 2025-06-08 | NCT07010523 | |
| Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors | Advanced or Metastatic Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2024-05-10 | NCT05693844 | |
| CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2023-07-17 | NCT05948033 | |
| CD70 Targeted CAR-T Cells in CD70 Positive Advanced/Metastatic Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 / Phase 2 | 2023-07-17 | NCT05947487 | |
| MSLN-targeted CAR-T Cells in Solid Tumors. | Mesothelin-positive Advanced Malignant Solid Tumors | Not yet recruiting | Phase 1 | 2023-03-24 | NCT05783089 |